Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESPONDER Trial - Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

NCT02948764 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT02948764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02948764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESPONDER Trial - Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer
Lead sponsor
Heidelberg University
Phase
Not applicable
Overall status
Completed
Start date
March 8, 2017
Completion date
September 15, 2019
Enrollment
452 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms